Neuronetics (STIM) Gains from Investment Securities (2017 - 2018)
Neuronetics' (STIM) quarterly Gains from Investment Securities came in at -$19000.0 in Q3 2018, down 111.8% year-on-year from $161000.0 in Q3 2017, and down 101.35% on a QoQ basis from $1.4 million in Q2 2018.
Neuronetics (STIM) Gains from Investment Securities (2017 - 2018) Analysis & Trends
Neuronetics (STIM) has 2 years of Gains from Investment Securities data on file, last reported at -$19000.0 in Q3 2018.
- On a quarterly basis, Gains from Investment Securities fell 111.8% year-over-year to -$19000.0 in Q3 2018; TTM through Dec 2018 was $1.4 million, a N/A change from a year earlier, with the FY2018 full-year figure at $1.4 million, up 615.13% from the prior year.
- Gains from Investment Securities for Q3 2018 stood at -$19000.0, down from $1.4 million in the prior quarter.
- Over the last five years, Gains from Investment Securities for STIM reached as high as $1.4 million in Q2 2018 and fell as low as -$21000.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Neuronetics | 126.30 Mn | 120.30 Mn | 16.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | -19,000.00 |
| Sep 30, 2018 | -19,000.00 |
| Jun 30, 2018 | 1.41 Mn |
| Jun 30, 2018 | 1.41 Mn |
| Mar 31, 2018 | 7,000.00 |
| Mar 31, 2018 | 7,000.00 |
| Dec 31, 2017 | -21,000.00 |
| Dec 31, 2017 | -21,000.00 |
| Sep 30, 2017 | 161,000.00 |
| Sep 30, 2017 | 161,000.00 |